News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ResMed.
RELATED STOCKHEAD STORIES
Experts
T.Rowe Price: How to shake off the market jitters and position for FY22
Health & Biotech
ScoPo’s Powerplays: ‘Prepare for a big jump in July’ as tax-loss selling in healthcare continues
Experts
Barclay’s bull or Pearce take? Building your portfolio for the post-COVID economy
Experts
MoneyTalks: Have you thought about your stock’s post-COVID environment? If not, this fundie thinks you should
News
Is inflation coming? These are the ASX stocks to buy if yields rise
News
RBA to maintain historic low rates until at least 2024
Experts
ScoPo’s powerplays: Market hit by profit-taking, but healthcare outperforms
Experts
ScoPo’s powerplays: Bullish on mobile X-ray company Micro-X
News
ScoPo’s powerplays: Morgans’ healthcare picks for 2021
News
The best asset class in 2021 could be one that’s been ignored for ‘nearly a decade’
Experts
Scopo’s powerplays: Feeling bullish for end of 2020
Experts
Scopo’s Health Powerplays: Show me the (grant) money
News
What ASX investors should look for in a COVID-19 earnings season
Experts
Scopo’s powerplays: Strap yourselves in for some M&A
News
‘Dividend recession’ heading for the Australian market
Health & Biotech
COVID-19 adds $9bn to top four ASX health stocks
News
